31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure

Show other versions (1)

Background. The purpose of this work was to further define the value of cardiac 31P magnetic resonance (MR) spectroscopy for patients with coronary artery disease and dilated cardiomyopathy. Methods and Results. Blood-corrected and 31T1-corrected 31P MR spectra of anteroseptal myocardium were obtain...

Full description

Bibliographic Details
Main Authors:	Neubauer, S, Krahe, T, Schindler, R, Horn, M, Hillenbrand, H, Entzeroth, C, Mader, H, Kromer, E, Riegger, G, Lackner, K, Ertl, G
Format:	Journal article
Language:	English
Published:	1992

Similar Items

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
by: Neubauer, S, et al.
Published: (1992)

Cardiac 31P-MR-spectroscopy in myocardial insufficiency
by: Krahe, T, et al.
Published: (1993)

[31P-cardio-MR-spectroscopy in myocardial insufficiency]
by: Krahe, T, et al.
Published: (1993)

[The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium]
by: Schindler, R, et al.
Published: (1992)

Direct measurements of relaxation times of phosphorus metabolites in the human myocardium
by: Schindler, R, et al.
Published: (1992)

Computed tomography and magnetic resonance tomography in cases of coronary heart disease
by: Lackner, K, et al.
Published: (1990)

[Computed tomography and magnetic resonance tomography in cases of coronary heart disease]
by: Lackner, K, et al.
Published: (1990)

Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T
by: Stoll, V, et al.
Published: (2016)

[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]
by: Krahe, T, et al.
Published: (1991)

In vivo 31P cardiac nuclear magnetic resonance spectroscopy. Methods and first clinical results
by: Krahe, T, et al.
Published: (1991)

Metabolic imaging in dilated cardiomyopathy
by: Neubauer, S
Published: (2011)

Direct measurement of spin-lattice relaxation times of phosphorus metabolites in human myocardium.
by: Neubauer, S, et al.
Published: (1992)

[Experimental and clinical possibilities of MR spectroscopy of the heart]
by: Neubauer, S, et al.
Published: (1991)

Experimental and clinical possibilities of MR spectroscopy of the heart
by: Neubauer, S, et al.
Published: (1991)

Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy
by: Marlevi, David
Published: (2021)

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
by: Neubauer, S, et al.
Published: (1997)

Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
by: Neubauer, S, et al.
Published: (1995)

Training and myocardial energy metabolism in patients with dilated cardiomyopathy: Analysis with P-31-MR spectroscopy
by: Wagner, D, et al.
Published: (2000)

Obesity modifies the energetic phenotype in dilated cardiomyopathy
by: Rayner, JJ, et al.
Published: (2021)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

Hyperubiquitination of proteins in dilated cardiomyopathy.
by: Weekes, J, et al.
Published: (2003)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
by: Lakdawala, N, et al.
Published: (2010)

Molecular and genetic dissection of dilated cardiomyopathy
by: Hafizah Khalidh
Published: (2015)

Indications for cardio-MRT
by: Lackner, K, et al.
Published: (1990)

[Indications for cardio-MRT]
by: Lackner, K, et al.
Published: (1990)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism.
by: Holloway, C, et al.
Published: (2012)

Reevaluating the genetic contribution of monogenic dilated cardiomyopathy
by: Mazzarotto, F, et al.
Published: (2020)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
by: Konstantinou, D, et al.
Published: (2014)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy
by: Konstantinou, D, et al.
Published: (2014)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
by: Neubauer, S, et al.
Published: (1997)

Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
by: Beer, M, et al.
Published: (2008)

Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
by: Song, W, et al.
Published: (2010)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
by: Ashrafian, H, et al.
Published: (2007)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
by: Borovikov, I, et al.
Published: (2013)

Ischemic versus dilated cardiomyopathy. incremental diagnostic value of Tissue Doppler Imaging
by: Papadopoulou, K, et al.
Published: (2006)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
by: Robinson, P, et al.
Published: (2002)

Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T 31P-cardiovascular magnetic resonance spectroscopy
by: Valkovič, L, et al.
Published: (2019)